Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Deseq2 design clarification

    Hi, I am working with human postmortem samples wherein I have 5 groups of subjects:

    A. Control: 20 samples
    B. First episode: 20 samples
    C. First episode Remission: 15 samples
    D. Second episode: 20 samples
    E. Second episode Remission: 15 samples


    Note that the progression of A to B to C to D to E is expected to be in phase (something like sinusoidal curve)

    I also have other parameters for the samples, which include: Age, Sex, RIN value, PMI (postmortem interval), pH of the sample


    I wish to test the difference of the 5 groups in ANOVA like analysis in DEseq2 but after controlling for Age, Sex, RIN value, PMI (postmortem interval), pH of the sample

    My phenotype table looks like this:

    Sample Age Sex Rin PMI pH DiseaseStage
    1 binned factor binned binned binned Control
    2 Control
    3 First episode
    . First episode
    . First episode
    . .
    . .
    90 Second episode Remission



    This is my design
    dds <- DESeqDataSet(se, design = ~ Age+Sex+RIN+PMI+pH+DiseaseStage)

    dds <- DESeq(dds, test = "LRT", reduced = ~ Age+Sex+RIN+PMI+pH)
    results(dds)

    I am hoping that I get 1 p-value for ANOVA like comparisons between the disease stage after controlling for Age, Sex, RIN, PMI and pH
    Also, I would like to know how many variables I can control for in the design? For instance, here I am using 5 (Age, Sex, RIN, PMI and pH) is it okay? If yes, is there any rule to how many variables to control for in the design?

Latest Articles

Collapse

  • seqadmin
    Current Approaches to Protein Sequencing
    by seqadmin


    Proteins are often described as the workhorses of the cell, and identifying their sequences is key to understanding their role in biological processes and disease. Currently, the most common technique used to determine protein sequences is mass spectrometry. While still a valuable tool, mass spectrometry faces several limitations and requires a highly experienced scientist familiar with the equipment to operate it. Additionally, other proteomic methods, like affinity assays, are constrained...
    04-04-2024, 04:25 PM
  • seqadmin
    Strategies for Sequencing Challenging Samples
    by seqadmin


    Despite advancements in sequencing platforms and related sample preparation technologies, certain sample types continue to present significant challenges that can compromise sequencing results. Pedro Echave, Senior Manager of the Global Business Segment at Revvity, explained that the success of a sequencing experiment ultimately depends on the amount and integrity of the nucleic acid template (RNA or DNA) obtained from a sample. “The better the quality of the nucleic acid isolated...
    03-22-2024, 06:39 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by seqadmin, 04-11-2024, 12:08 PM
0 responses
25 views
0 likes
Last Post seqadmin  
Started by seqadmin, 04-10-2024, 10:19 PM
0 responses
29 views
0 likes
Last Post seqadmin  
Started by seqadmin, 04-10-2024, 09:21 AM
0 responses
25 views
0 likes
Last Post seqadmin  
Started by seqadmin, 04-04-2024, 09:00 AM
0 responses
52 views
0 likes
Last Post seqadmin  
Working...
X